Form 8-K · Current Report · Filed 2025-03-10
Elevance Health Reaffirms 2025 Earnings Guidance
Elevance Health, Inc. has reaffirmed its 2025 earnings guidance, anticipating shareholders' earnings to be between $30.40 and $31.10 per diluted share, which includes approximately $3.75 per diluted share of net unfavorable items. Excluding these items, the company expects adjusted shareholders' earnings to be between $34.15 and $34.85 per diluted share. The company also expects 2025 year-end total medical enrollment to align with previous guidance, including a forecast for Medicare Advantage membership of 2.2 to 2.25 million members.
- Filer
- Elevance Health Inc. ELV · NYSE
- Filed
- Accession
- 0001193125-25-050889
- CIK
- 0001156039
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Regulation FD Disclosure
Market reaction
Close before filing
$409.46
Next session
+3.1%
Since filing
-8.2%
Latest close
$375.84
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from ELV reporting the same item, with the next session's move:
About Elevance Health Inc.
Elevance Health Inc., formerly known as Anthem, is a prominent health insurance company in the United States. Its primary function is to provide a wide range of health insurance products and related services to a diverse customer base, including individuals, families, and businesses. Elevance Health focuses on enhancing health and well-being by offering managed care plans tailored to the varying needs of its clients. With a robust portfolio, Elevance Health caters to multiple sectors within the healthcare industry, influencing stakeholders such as healthcare providers, pharmaceutical companies, and medical technology firms. The company plays a critical role in the healthcare market by negotiating coverage terms, managing costs, and ensuring policyholders have access to necessary medical services. As one of the largest health insurers in the nation, Elevance Health holds significant market influence, contributing to shaping healthcare policies and practices through its vast network and strategic partnerships. By leveraging technology and data analytics, the company aims to improve patient outcomes, streamline insurance processes, and foster advancements in personalized healthcare solutions.
Never miss another ELV filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.